News | Stents | June 02, 2022

FDA Class 1 Recall on iCast Stent for Separation Risk That May Cause Harm

This information was updated on June 8, 2022, to include information and clarity from an FDA spokesperson.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

June 2, 2022 — According to the U.S. Food and Drug Administration (FDA), Atrium Medical Corporation is recalling the iCast Covered Stent System after receiving increased customer complaints about the separation of the balloon or catheter hub from the delivery system when the delivery system is removed from a person. This issue seems to occur most often when the stent system is used outside of the indications for use, for example to treat vascular conditions.

If a separation occurs and the balloon is not fully deflated before the device is removed from a person’s blood vessel, it may cause the procedure to take longer than expected, exposing the person to additional anesthesia and/or imaging chemicals known as contrast. The separated portion also may remain in the body after the delivery catheter is removed, potentially leading to vascular occlusion. Depending on the location of failure, occlusion may lead to amputation, embolism, loss of organ function, organ infarction, and tissue infarction.

There have been 75 complaints, nine injuries, and no deaths related to this device issue.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death.

According to an FDA spokesperson, "FDA’s regulatory definition of a medical device recall, 21 CFR 7.3(g), includes “removal or correction” of a device that FDA considers to be in violation of the law. Atrium’s medical device recall was a “correction” and the title of the company’s March 3, 2022 letter is Urgent Medical Device Correction, which accurately reflects the fact that this medical device recall was a correction."

The FDA spokesperson also stated that the FDA classified this action as a Class I recall, and referenced this link for additional information: https://www.fda.gov/medical-devices/medical-device-recalls/atrium-medical-corporation-recalls-icast-covered-stent-potential-balloon-or-catheter-hub-separation?utm_medium=email&utm_source=govdelivery.  

Recalled Product

  • Product Name: iCast Covered Stent
  • Product Lot Numbers: See recall database entry
  • Distribution Dates: December 31, 2018, to March 31, 2022
  • Devices Recalled in the U.S.: 68,812
  • Date Initiated by Firm: March 3, 2022

Device Use

The iCast Covered Stent System is a balloon expandable stent that can be delivered using a catheter to hold open and support the walls of the structures within the body. It is currently indicated for use in the United States as a stent to hold open the airways (tracheobronchial stent).

Reason for Recall

According to the FDA, Atrium Medical Corporation is recalling the iCast Covered Stent System after receiving increased customer complaints about the separation of the balloon or catheter hub from the delivery system when the delivery system is being removed from a person. This issue seems to occur most often when the stent system is used outside of the indications for use, for example to treat vascular conditions.

If a separation occurs and the balloon is not fully deflated before the device is removed from a person’s blood vessel, it may cause the procedure to take longer than expected, exposing the person to additional anesthesia and/or imaging chemicals known as contrast. The separated portion also may remain in the body after the delivery catheter is removed, potentially leading to vascular occlusion. Depending on the location of failure, occlusion may lead to amputation, embolism, loss of organ function, organ infarction, and tissue infarction.

There have been 75 complaints, nine injuries, and no deaths related to this device issue.

Who May be Affected

  • Health care personnel who use the iCast Covered Stent System to treat vascular conditions in their patients, especially if the system is used for an off-label vascular use.
  • People who have catheter-based vascular procedures using the iCast Covered Stent System.

What to Do

On March 3, 2022, Atrium Medical issued an Urgent Medical Device Correction letter to all customers.

Atrium instructed users to read the following deflation and withdrawal instructions prior to using this device:

  • Deflate the balloon by pulling vacuum on the inflation device to its maximum volume and allow sufficient time for full deflation.
    • Note: Deflation times may vary based on balloon size, catheter length, and inflation media used. Deflations may take longer with larger devices and higher concentrations of contrast.
  • Visually verify full deflation of the balloon via fluoroscopy before attempting to withdraw the delivery system.
  • Do not force withdrawal of the delivery system if resistance is encountered. Forcing withdrawal may result in damage to the delivery system, including separation of the balloon or catheter hub from the delivery catheter.
  • If unable to fully deflate the balloon or resistance is encountered, remove the delivery system and introducer sheath as one unit.
    • Note: it is recommended that the guidewire remain across the lesion until the procedure is completed.
    • While maintaining guidewire position and negative pressure on the inflation device slowly withdraw the delivery catheter.
    • Immediately stop using devices from affected lots.

Health professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report online.
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.

For more information: www.fda.gov

Related Content

News | Cardiovascular Business

June 28, 2022 — – Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers ...

Home June 28, 2022
Home
News | Cardiovascular Business

June 22, 2022 — Dr. Thomas Forbes, an interventional cardiologist, has joined Joe DiMaggio Children’s Hospital as its ...

Home June 22, 2022
Home
News | Cardiovascular Business

June 7, 2022 — Michael Bowdish, MD, MS, a national leader in cardiac surgery and among a handful of cardiac surgeons ...

Home June 07, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of May ...

Home June 01, 2022
Home
News | Cardiovascular Business

May 25, 2022 — MedStar Heart & Vascular Institute announced that Thomas E. MacGillivray, MD, has been named physician ...

Home May 25, 2022
Home
News | Cardiovascular Business

May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific ...

Home May 16, 2022
Home
News | Cardiovascular Business

May 12, 2022 — Abbott announced a new partnership with Women as One to launch a new program designed to train more ...

Home May 12, 2022
Home
News | Cardiovascular Business

May 12, 2022 — NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified ...

Home May 12, 2022
Home
News | Cardiovascular Business

May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its new ...

Home May 11, 2022
Home
Feature | Cardiovascular Business

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...

Home May 09, 2022
Home
Subscribe Now